SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : 3D Printing
DDD 2.170+0.5%Nov 14 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: ACAN4/30/2013 11:44:47 PM
1 Recommendation   of 902
 
Organovo to Present at the 12th Annual Needham Healthcare Conference

SAN DIEGO, April 25, 2013 /PRNewswire/ -- Organovo Holdings, Inc. ( ONVO) ("Organovo"), a creator and manufacturer of functional, three-dimensional human tissues for medical research and therapeutic applications, has been invited to present at the 12th Annual Needham Healthcare Conference, which will be held in New York April 30 through May 1, 2013. Organovo's Chairman and Chief Executive Officer, Keith Murphy, will present on May 1st, at 3:00 p.m.

Needham & Company's 12th Annual Healthcare Conference is a high-impact forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostics sectors. One-on-one meetings will be available for qualified investors. This conference is by invitation only. The conference will be held at The Westin Grand Central Hotel, 212 East 42nd Street, NY, NY 10017.

Today's action could be a precursor to an institutional investment getting in on the ground floor of this additive biotechnology 3D stock, and its many possibilities.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext